MOUD Clarity is intended to aid, not replace, medical decision making. None of the information presented in MOUD Clarity should be used as sole justification for providing or not providing care or medications to a patient.
Poor adherence to medications for opioid use disorder (MOUD) protocols for individuals diagnosed with opioid use disorder (OUD) could result in the relapse and increased risk of both non-fatal and fatal overdose. Despite this risk, healthcare professionals often have limited time with patients and might not be able to obtain a patient’s full health history during brief visits. Additionally, missed refill appointments may be a red flag for discontinuation that is often not addressed by healthcare professionals due to resource constraints for tracking missed appointments and outreach.
With the development of MOUD Clarity, healthcare professionals will be able to identify patients at risk of MOUD treatment discontinuation by receiving an alert if a patient has run out of an MOUD drug (buprenorphine) based on the date of the last dispensation and the days supply. If the patient has run out of an MOUD drug for longer than the PDMP specified threshold, the MOUD Clarity alert will display on the state indicators tile of the Patient Report.
MOUD Clarity displays dispensations for humans treated with buprenorphine for MOUD.
Healthcare professionals will see the MOUD Clarity indicator on the Patient Report whether they are accessing the Patient Report via their state’s PMP AWARxE instance or Bamboo Health’s Gateway integration.
MOUD Clarity relies on PDMP data received by Bamboo Health as of the time of generation of the Patient Report. As such, Bamboo Health does not warrant that the data relied upon by MOUD Clarity is complete, accurate, or error-free. Alerts may appear for patients who do not have gaps in MOUD treatment or may otherwise be limited if the data is unavailable, delayed, or incomplete.
MOUD Clarity is intended to inform healthcare professionals of potential gaps in MOUD treatment and should not be used in any other way.
If the user clicks on Details in the lower right corner of the State Indicators tile, additional information will appear regarding the reason the indicator was activated to include how many days of MOUD supply have been missed.
If enabled by the PDMP, when an MOUD Clarity alert is activated, an email will also be sent to all providers and their delegates who have prescribed an MOUD to that patient in the last 45 days.
If enabled by the PDMP, when the MOUD Clarity alert is activated, it will also display on authorized users' AWARxE Dashboards for a period of time as determined by the PDMP.
Bamboo Health defines MOUD Buprenorphine based on FDA label and specific formulations per the FDA list of drugs approved as MOUD. This data is consistently obtainable through dispensation and federally available data. If drugs are prescribed or used off-label, Bamboo Health is not able to determine the off-label usage and must rely on approved usage only.